Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adolescent 11
- Adult 9
- Aged 1
- Age Factors 4
- AIDS-Related Opportunistic Infections 1
- AIDS Serodiagnosis 2
- Anti-HIV Agents 4
- Anti-Infective Agents 2
- Anti-Retroviral Agents 6
- Antibody Affinity 1
- antiretroviral therapy 2
- Antiretroviral Therapy, Highly Active 1
- Article 4
- Atazanavir Sulfate 1
- Cardiovascular Diseases 1
- Case-Control Studies 1
- CD4 Lymphocyte Count 4
- Child 4
- Child, Preschool 4
- children 1
- Chromatography, Liquid 1
- Comorbidity 1
- Contraception 1
- cotrimoxazole 1
- Cross-Sectional Studies 3
- Darunavir 1
- Delivery of Health Care 1
- Diabetes Mellitus 1
- Dideoxynucleosides 1
- Disclosure 1
- Drug Resistance, Viral 3
- Drug Therapy, Combination 1
- Educational Status 2
- Eligibility Determination 1
- Epidemics 1
- Family Planning Services 1
- Female 10
- Genotype 1
- Genotyping Techniques 1
- Healthcare Disparities 1
- Health Care Surveys 1
- Health Knowledge, Attitudes, Practice 2
- Health Services Accessibility 4
- Health Services Administration 1
- Health Services Research 1
- Health Surveys 4
- HIV 2
- HIV-1 3
- HIV Antibodies 1
- HIV Infections 13
- Humans 13
- Hypertension 1
- Incidence 1
- Infant 2
- Infectious Disease Transmission, Vertical 1
- Kenya 3
- Lopinavir 1
- Male 9
- Marital Status 2
- Mass Screening 1
- Middle Aged 8
- Mutation 2
- Neoplasms 1
- Noncommunicable Diseases 1
- Outcome and Process Assessment, Health Care 1
- Patient Acceptance of Health Care 2
- Phylogeny 1
- Plasma 1
- Point-of-Care Systems 1
- pol Gene Products, Human Immunodeficiency Virus 1
- Population Surveillance 1
- Pregnancy 1
- Prevalence 4
- Proportional Hazards Models 1
- Protease Inhibitors 1
- Random Allocation 1
- Reproductive Behavior 1
- Respiratory Tract Diseases 1
- Retrospective Studies 2
- Reverse Transcriptase Inhibitors 1
- Risk Factors 2
- Ritonavir 1
- Rural Population 2
- Self Disclosure 1
- Sex Factors 2
- Surveys and Questionnaires 2
- Tandem Mass Spectrometry 1
- testing 1
- Treatment Failure 2
- Treatment Outcome 1
- Trimethoprim, Sulfamethoxazole Drug Combination 2
- Urban Population 1
- Viral Load 3
- viral suppression 1
- World Health Organization 1
- Young Adult 9
Personal Author
Corporate Author
Place as Subject
- Kenya 10
- South Africa 1
Resource Type General
Keywords
Select all docs (Max 200)
1 -
13 of 13 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adolescent (11)
- Adult (9)
- Aged (1)
- Age Factors (4)
- AIDS-Related Opportunistic Infections (1)
- AIDS Serodiagnosis (2)
- Anti-HIV Agents (4)
- Anti-Infective Agents (2)
- Anti-Retroviral Agents (6)
- Antibody Affinity (1)
- antiretroviral therapy (2)
- Antiretroviral Therapy, Highly Active (1)
- Article (4)
- Atazanavir Sulfate (1)
- Cardiovascular Diseases (1)
- Case-Control Studies (1)
- CD4 Lymphocyte Count (4)
- Child (4)
- Child, Preschool (4)
- children (1)
- Chromatography, Liquid (1)
- Comorbidity (1)
- Contraception (1)
- cotrimoxazole (1)
- Cross-Sectional Studies (3)
- Darunavir (1)
- Delivery of Health Care (1)
- Diabetes Mellitus (1)
- Dideoxynucleosides (1)
- Disclosure (1)
- Drug Resistance, Viral (3)
- Drug Therapy, Combination (1)
- Educational Status (2)
- Eligibility Determination (1)
- Epidemics (1)
- Family Planning Services (1)
- Female (10)
- Genotype (1)
- Genotyping Techniques (1)
- Healthcare Disparities (1)
- Health Care Surveys (1)
- Health Knowledge, Attitudes, Practice (2)
- Health Services Accessibility (4)
- Health Services Administration (1)
- Health Services Research (1)
- Health Surveys (4)
- HIV (2)
- HIV-1 (3)
- HIV Antibodies (1)
- HIV Infections (13)
- Humans (13)
- Hypertension (1)
- Incidence (1)
- Infant (2)
- Infectious Disease Transmission, Vertical (1)
- Kenya (3)
- Lopinavir (1)
- Male (9)
- Marital Status (2)
- Mass Screening (1)
- Middle Aged (8)
- Mutation (2)
- Neoplasms (1)
- Noncommunicable Diseases (1)
- Outcome and Process Assessment, Health Care (1)
- Patient Acceptance of Health Care (2)
- Phylogeny (1)
- Plasma (1)
- Point-of-Care Systems (1)
- pol Gene Products, Human Immunodeficiency Virus (1)
- Population Surveillance (1)
- Pregnancy (1)
- Prevalence (4)
- Proportional Hazards Models (1)
- Protease Inhibitors (1)
- Random Allocation (1)
- Reproductive Behavior (1)
- Respiratory Tract Diseases (1)
- Retrospective Studies (2)
- Reverse Transcriptase Inhibitors (1)
- Risk Factors (2)
- Ritonavir (1)
- Rural Population (2)
- Self Disclosure (1)
- Sex Factors (2)
- Surveys and Questionnaires (2)
- Tandem Mass Spectrometry (1)
- testing (1)
- Treatment Failure (2)
- Treatment Outcome (1)
- Trimethoprim, Sulfamethoxazole Drug Combination (2)
- Urban Population (1)
- Viral Load (3)
- viral suppression (1)
- World Health Organization (1)
- Young Adult (9)
- :Wafula, Rose ;Masyuko, SarahMay 1 2014 | J Acquir Immune Defic Syndr. 66(Suppl 1):S98-105.:BackgroundIncreasing access to care and treatment for HIV-infected persons is a goal in Kenya’s response to the HIV epidemic. Using data from the se...
- :Rhee, Soo-Yon ;Jordan, Michael R.Dec 30 2015 | PLoS One. 10(12).:The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and ...
- :Dziuban, Eric J. ;DeVos, Joshua8 2017 | Pediatr Infect Dis J. 36(8):758-760:A survey of 461 HIV-infected Kenyan children receiving antiretroviral therapy found 143 (31%) failing virologically. Drug resistance mutations were fo...
- :Kim, Andrea A. ;Mukui, Irene11 13 2016 | AIDS. 30(17):2685-2695:Objectives:To assess the impact of undisclosed HIV infection and antiretroviral (ARV) therapy (ART) on national estimates of diagnosed HIV and ART cov...
- :Onywera, Harris ;Maman, DavidFeb 08 2017 | PLoS One. 12(2).:HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa with the rollout of antiretroviral (ARV) therapy....
- :Ng’eno, Bernadette ;Mwangi, AnnMay 1 2014 | J Acquir Immune Defic Syndr. 66(Suppl 1):S82-S88.:BackgroundsIn Kenya, mathematical models estimate that there are approximately 220,000 children aged less than 15 years infected with HIV. We analyzed...
- :Achwoka, Dunstan ;Waruru, AnthonyApril 03 2019 | BMC Public Health. 19:BackgroundOver the last decade, the Kenyan HIV treatment program has grown exponentially, with improved survival among people living with HIV (PLHIV)....
- :Moyo, Sizulu ;Young, Peter W.Aug 10 2018 | PLoS One. 13(8).:ObjectiveTo assess changes and equity in antiretroviral therapy (ART) use in Kenya and South Africa.MethodsWe analysed national population-based house...
- :Kim, Andrea A. ;Mukui, IreneMar 01 2016 | PEPFAR:BackgroundIn 2014, the Joint United Nations Programme on HIV/AIDS (UNAIDS) called for 90% of persons living with HIV (PLHIV) to know their status, 90%...
- :Odhiambo, Jacob O. ;Kellogg, Timothy A.May 1 2014 | J Acquir Immune Defic Syndr. 66(Suppl 1):S116-S122.:BackgroundIn 2007, 29% of HIV-infected Kenyans in need of antiretroviral therapy (ART), based on an immunologic criterion of CD4 ≤350 cells per micr...
- :Maman, David ;Zeh, ClementJul 31 2015 | AIDS. 2015; 29(12):1557-1565.:Introduction:Direct measurement of antiretroviral treatment (ART) program indicators essential for evidence-based planning and evaluation – especial...
- :Ngeno, Bernadette ;Waruru, AnthonyOctober 25 2018 | J Adolesc Health. 64(2):242-249:Purpose:Informing adolescents of their own HIV infection is critical as the number of adolescents living with HIV increases. We assessed the associati...
- :Ngugi, Evelyn W. ;Kim, Andrea A.May 1 2014 | J Acquir Immune Defic Syndr. 66(Suppl 1):S75-S81.:BackgroundPrevention of unplanned pregnancies is a critical element in the prevention of mother-to-child transmission of HIV infection, but its potent...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.